Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Limiting the Influence of Pharmaceutical Industry Gifts on Physicians: Self-Regulation or Government Intervention
Journal of General Internal Medicine, 09/22/09

Grande D – The author examines and critiques the wide ranging legislative strategies pursued to limit the influence of pharmaceutical gifts on physicians and concludes with suggestions for policymakers and the profession to limit influence and preserve public trust.

Related Articles

Takeda to Establish Four Sales and Marketing Subsidiaries to Expand its Operations in Mexico, Turkey and Five Other Countries in Europe
Takeda Pharmaceuticals North America, 10/02/09    Relevance Score: 68%

Par pharmaceutical receives final approval to market generic ultram er
Par Pharmaceutical, 11/17/09    Relevance Score: 67%

King Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
King Pharmaceuticals, 11/16/09    Relevance Score: 67%

APP Pharmaceuticals Receives Approval for Sumatriptan Succinate Injection, USP
American Pharmaceutical Partners, 10/09/09    Relevance Score: 67%

APP Pharmaceutical Supports New USP Standards for Unfractionated Heparin
American Pharmaceutical Partners, 10/02/09    Relevance Score: 67%

Today in Regulatory Issues...keeping you current

Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09

Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09

Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09

 See all of Regulatory Issues

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address